Abstract: MicroRNAs (miRNAs), through mRNA degradation or repression, act as key regulator of gene expression. Our aim was to identify specific miRNAs that are expressed in endometrium of women with and without endometriosis. We profiled the expression of 287 miRNAs in paired eutopic and ectopic endometrium and isolated endometrial cells using microarray and validated the expression of selected miRNAs using realtime PCR. Based on global normalization, 65 of these miRNAs were identified to be expressed above the threshold levels set during the analysis in the endometrium of women without endometriosis with a progressive decline in expression in paired eutopic and ectopic endometrium.
Statistical analysis (ANOVA) identified 48 of these miRNAs as differentially expressed among these tissues and 32 miRNAs between isolated endometrial stromal (ESC) and glandular epithelial (GEC) cells (P<0.05). The expression of hsa-miR20a, hsa-miR21, hsa-miR26a, hsa-miR18a, hsa-miR206, hsamiR181a, and hsa-miR142-5p, predicated to target many genes, including TGF-βR2, ERα, ERβ and PR, respectively was validated in these tissues and cells using realtime PCR. Treatment of ESC and GEC with 17β estradiol and medroxyprogesterone acetate (10 -8 M) differentially regulated the expression of hsamiR20a, hsa-miR21, hsa-miR26a, which in part reversed following co-treatment with ICI-182780 and RU-486 (10 -6 M), respectively (P<0.05). In conclusion, we provided evidence for the expression of a number of differentially expressed miRNAs in eutopic/ectopic endometrium and isolated endometrial cells, opening up the possibility that aberrant/altered expression of some miRNAs whose expression is regulated by the ovarian steroids may influence the expression of specific target genes with central roles in normal endometrial cellular activities and pathogenesis of endometriosis.
Introduction
Endometrium is a dynamic tissue that undergoes specific cyclic changes under the control of ovarian steroids during the reproductive years. The ovarian steroids also play a central role in pathogenesis of several uterine disorders, including endometriosis, which is characterized by the presence of endometrial tissue fragments outside the uterine cavity. Both eutopic and ectopic endometrium express ERα and ERβ with predominantly higher levels of ER-α in ectopic lesions (Matsuzaki et al., 2000 (Matsuzaki et al., , 2001 . Although eutopic endometrium expresses both PR-A and PR-B, ectopic endometrium has been reported to only express PR-A (Attia et al., 2000) . In addition, altered local estrogen metabolism in ectopic endometrium has been associated with progression of endometriosis (Bulun et al., 2006) . Despite the importance of ovarian steroids in pathogenesis of endometriosis the nature of the processes that lead to establishment endometriosis remains unknown. Conventional and recent large-scale gene expression studies have provided further evidence reflecting the molecular environments that differentiate normal endometrium from disorders affecting this tissue including endometrial cancer, adenomyosis and endometriosis (Hever et al., 2006; Wu et al., 2006; Ponnampalam et al., 2004; Matsuzaki et al., 2004; Riesewijk et al., 2003; Risinger et al., 2003; Kao et al., 2002; Eyster et al., 2002) . The product of many of these genes have been considered to contribute toward normal endometrial cyclic changes and associated endometrial disorders, however the expression, regulation and biological significance of many of them in normal physiological and pathophysiology of endometrium remains to be established.
Recent identification of a group of small noncoding RNA referred to as microRNAs (miRNAs) and their function analysis has led to the discovery of their key regulatory function in gene expression.
MicroRNAs are expressed as 70 to 90 base pair (bp) precursor RNA that are processed by the nuclease Drosha and transported into the cytoplasm where they are further cleaved by dicer resulting in formation of a 17 to 23 bp mature miRNAs (Calin and Croce 2006a, 200b; Jovanovic and Hengartner, 2006; Engels and Hutvagner 2006; Zeng 2006) . These mature miRNAs complex with the target sequences in a complementary manner similar to that occur during RNA interference (RNAi) process, however their target sequences could be at least partially complementary to the miRNA (Bartel 2004; Pillai 2005) . To date several hundred miRNA have been cloned and/or predicated, each with the ability to modulate the expression of their target genes through cleavage or translational regression. The expression of many of these miRNAs has been identified in a number of mammalian cells and tissues including humans (Zhao et al., 2006 , Roldo et al., 2006 , however their biological significance in many cellular processes remains to be established. Evidence indicates that the genes for many of miRNAs have been located at chromosomal fragile sites or regions of cytogenetic abnormalities associated with cancer and other disorders and their altered expression has been associated with tumorogenesis. Evidence also supports their importance in developmental processes as well as other cellular activities involving cell growth, differentiation and apoptosis (Ambros 2004; Jovanovic and Hengartner, 2006; Engels and Hutvagner 2006; Zeng 2006 ).
Many of the above processes are involved in cyclic endometrial changes and the establishment and progression of endometriosis, suggesting the implication of specific miRNAs in regulating the endometrial expression of genes whose products influence the outcome of this and other endometrial disorders. The aim of the present study was to profile the expression of miRNAs in eutopic and ectopic endometrium as well as in isolated endometrial stromal and glandular epithelial cells using microarray. In addition, we validated the expression of several of these miRNAs selected based on their predicated target genes, including TGF-β, TGF-β receptors, ERα, ERβ and PR, recognized to play a central role in endometriosis, in these tissues and cells using realtime PCR. We also examined the influence of ovarian steroids, 17β estradiol and medroxyprogesterone acetate, as well as the effect of ICI-182780, a pure antiestrogen and RU-486, a selective progesterone receptor modulator on the expression of these miRNAs in endometrial cells.
Materials and Methods
All the materials for isolation of endometrial stromal and glandular epithelial cells and culture media were purchased from commercial sources as previously described (Chegini et al., 1999) . MirVana RNA isolation and enrichment kits and miRNA Bioarray slides for human miRNA detection were purchased from Ambion (Austin, TX) and realtime PCR reagents were purchased from Applied Biosystem (Foster city, CA). 17β estradiol (E2), medroxyprogesterone acetate (MPA) and RU486
(Mifepristone) were purchased from Sigma Chemical Co. (St. Louis, MO). ICI-182780 (Fulvestrant) was purchased from Tocris Cookson, Inc. (Ballwin, MO) and charcoal-stripped fetal calf serum was purchased from (Hyclone, Logan, UT) and utilized as previously described (Ripley et al., 2001 ).
Tissue collection
Portions of endometrium from women without endometriosis (N=4; EN), paired eutopic and ectopic endometrium (N=4; EU and EC) and ectopic endometrium (N=4; EE, tissues without the paired eutopic endometrium) were collected from premenopausal women who were scheduled to undergo hysterectomy for indications related to symptomatic leiomyomas or endometriosis, respectively. The patients age ranging from 27 to 39 years and were not taking any medication including hormonal therapy for pervious 3 months prior to surgery. Based on their last menstrual period and endometrial histology the tissues were from early-mid secretory phase of the menstrual cycle. The endometriosis was identified as staged III according to ASRM guideline. The tissues were collected at the University of Florida affiliated Shands Hospital under a study protocol approved by the Institutional Review Board at the University of Florida without requiring written informed consent. Immediately after collection the tissues were snapped frozen and kept in liquid nitrogen for further analysis, or used for cell isolation and culturing.
Endometrial Cell Isolation and Culturing
A small portion of endometrial tissues was used for isolation of endometrial stromal (ESC) and glandular epithelial (GEC) cells as previously described (Chegini et al., 1999 
miRNA Expression Analysis
Total RNA was isolated from the above tissues and cells were subjected to mirVana miRNA isolation kit according to manufacturer's instructions (Ambion). Briefly, 30 µg of total RNA was loaded onto the top of a column filled with a denaturing acrylamide gel matrix and the miRNA fraction was obtained by mixing RNA with 2X sample buffer and flashPAGE purification using flashPAGE precast Gels and the flashPAGE Fractionator System. The RNA quality, yield and size of miRNA fractions were analyzed using Agilent 2100 Bioanalyzer (Agilent Technologies, Foster City, CA).
miRNA labeling and Hybridization
Purified miRNA isolated from the above samples were labeled at 3′ amine-modified tails using 
Array Data Processing and Analysis
Following hybridization, the slides were washed, dried and scanned on a GenePix 4000B Array Scanner (Molecular Devices Corporation, Sunnyvale, CA). The miRNA spots and their intensity were determined using GenePix Pro 6.0 software as recommended by the manufacturer. Background-adjusted spot intensity for each miRNA was subjected to a global variance stabilization normalization (VSN) procedure (Huber et al., 2002) recommended by Ambion (http://www.ambion.com/techlib/ resources/miRNA-array/da-bioarrays.html) and described by Davison et al., 2006 . This analysis identifies differentially expressed miRNA with precision and quadratic relationship between the variance with lesser focus on absolute expression and fold-change difference. The expression values were subjected to unsupervised hierarchical clustering and Tree-View analysis (Davison et al., 2006) .
(Author: Does this microarray data have a repository accession number? See instructions to authors)

Treatments
To determine whether ovarian steroids regulate the endometrial expression of miRNAs 1X10 6 ESC and GEC cells were seeded in 6-well culture dishes and incubated for 48 hrs as described above. The cells were washed and incubated under serum-free condition for 24 h and then treated with E2 (10 -8 M),
MPA (10 -8 M), ICI-182780 (10 -6 M), RU486 (10 -6 M), E2+ICI, or MPA+RU486 added to phenol red-free medium containing 2% charcoal-stripped FBS for 24 h (Ripley et al., 2001 ).
Realtime Polymerase Chain Reaction
Realtime PCR was carried out to verify the expression of hsa-miR-20a, hsa-miR-21, hsa-miR26a, hsa-miR18a, hsa-miR181a, hsa-miR206 and hsa-miR142-5p selected based on their target genes, which include TGF-β, TGF-β receptor, ERα, ERβ and PR, respectively). Briefly, 10 ng of total RNA was reverse transcribed to cDNA with stem-loop primers for the above miRNAs and TaqMan® miRNA Reverse Transcription kit. Quantitative realtime PCR was carried out using an Applied Biosystems 7300
Realtime PCR System and a Taqman Universal PCR Master Mix at 95℃ for 10 min, 95℃ 15 sec and 60℃ for 1 min for 40 cycles. The results were analyzed using comparative method following normalization of expression values to U6 and hsa-let_7a expression as recommended by the manufacturer using Sequence Detection Software 2.2.1 (Applied Biosystems). These miRNAs were selected for verification based on their predicated target genes listed in the Sanger miRBase database (http://microrna.sanger.ac.uk/sequences, Adams et al., 2007) .
Statistical Analysis
All the in vitro experiments were performed three times using independent cell cultures. Where appropriate the results are expressed as mean ± standard error (SEM) and statistically analyzed using Student's t testing for comparison of two groups and ANOVA for multiple comparisons, with p<0.05 considered significant.
Results
Using miRNA Bioarray Slides containing 287 human miRNA probe sets we first assessed their expression profile in the endometrium of women without endometriosis (EN), paired eutopic (EU) and ectopic (EC) endometrium as well as ectopic endometrium (EE; without paired eutopic tissue). We also profiled the expression of these miRNAs in endometrial stromal (ESC) and glandular epithelial cells (Table 1 ). Figure 1 illustrates the unsupervised hierarchical clustering and Tree-View analysis of these differentially expressed miRNAs in EN, EU, EC and EE with each tissue separated into their respective subgroup some with overlapping relatedness Using a similar analysis we identified 32 miRNAs as differentially expressed in ESC and GEC (Table 2) , a significantly lower numbers as compared to EN. These miRNAs were commonly expressed in the original endometrial tissues used for isolation of ESC and GEC.
We selected hsa-miR20a, hsa-miR21, hsa-miR26a, hsa-miR18a, hsa-miR181a, hsa-miR206 and hsa-miR142-5p and validated their expression in the above tissues and cells using realtime PCR. The selection of these miRNAs was based on their predicated target genes (Table 3) , which include TGF-β, TGF-β receptors, ERα, ERβ and PR (http://microrna.sanger.ac.uk/sequences, Adams et al., 2007) .
Although these miRNAs are expressed in EN, EC, EU and EE as well as GEC and ESC, the microarray analysis indicated no significant difference in level of their expression with the exception of hsa-miR21, hsa-miR26a and hsa-miR142-5p (Table 1 and Table 2 ). Considering the PCR threshold cycle (Ct) values the order of relative expression of these miRNAs in EN was hsa-miR20a>hsa-miR21>hsa-miR26a and for the remaining miRNAs was hsa-miR18a>hsa-miR181a>hsa-miR142-5p>hsa-miR206.
Following individual normalization for comparative analysis by setting the expression value of each miRNA in EN independently as 1, the relative level of expression of hsa-miR21 and hsa-miR26a was lower in EC and EE as compared to EN and EU ( Fig. 2A ; P<0.05). In contrast, the relative expression of has-miR20a was higher in EC and EE than EN and EU. The level of expression of hsamiR18a, (but not consistently hsa-miR206 (ERα) and hsa-miR181a (ERβ) was higher in EU, EC and EE as compared to EN, while the expression hsa-miR142-5p (PR) was higher in EU as compared to EC ( Fig.   2B ; P<0.05). The level of expression of these miRNAs did not display a similar trend as their mean expression values obtained from the microarray (Table 1 ).
The expression of hsa-miR20a, hsa-miR21 and hsa-miR-26a was also differentially expressed in ESC and GEC (Fig. 3) . Since the expression of miRNAs is altered in cell cultures and cellular differentiation as compared to their levels at tissue levels (Szafranska et al., 2007) , we used human endometrial epithelial cell (HES) line for comparative analysis with ESC and GEC isolated from the same EN. Setting the expression of hsa-miR20a, hsa-miR21 and hsa-miR26a in HES cells as 1, the results indicated that GEC expressed more hsa-miR20a and hsa-miR-21 as compared to hsa-miR26a, whereas ESC expressed higher levels of hsa-miR26a and hsa-miR21 with a low level of hsa-miR20a as compared to HES (Fig. 3, P<0 .05).
We next examined the effect of ovarian steroids on the expression of hsa-miR20a, hsa-miR-21
and hsa-miR26a in ESC and GEC. The results indicated that, E2 ( 
Discussion
MicroRNAs are a novel class of regulatory molecules with the ability to control gene expression at the posttranscriptional level through degradation, repression or silencing. Since each miRNA has been predicted to have a broad range of target mRNA based on degree of sequence homology, it is estimated that the expression of approximately 30% of genes are the potential target of miRNA regulatory function (Yu et al., 2006) . As such changes in the expression of even a single miRNA could have a significant impact on the outcome of diverse cellular activities regulated by the product of these genes. In the present study we profiled 287 human miRNAs and identified the expression of considerable number of them in the endometrium of women without endometriosis (EN) which progressively declined in paired eutopic (EU) and ectopic (EC) endometrium,. Based on statistical analysis of the mean expression values, 48 of these miRNAs were identified as differentially expressed among these tissues. There was also a progressive decline in the level of expression of these miRNAs (Table 1 ) from EN to EU, EC and EE (ectopic endometrium without paired eutopic tissues). These miRNAs were also expressed in isolated endometrial cells with a significant reduction in numbers and level of expression (Table 2 ) as compared to the original tissues used for isolating these cells. As such the results suggest that absence/altered expression of a substantial number of miRNAs in ectopic endometrium could result in expression re-programming of a large number of genes as compared to paired eutopic endometrium as well as comparing EN to EU. As a result gene expression re-programming the endometrial fragments derived from women with endometriosis may have an altered regulatory mechanism that leads to their survival and growth at the ectopic sites as compared to tissues derived from women without endometriosis.
We recognize that relatively low number of tissues (N=16) collected from the early-mid secretory phase of the menstrual cycle as a limitation of our study. As such further study is necessary to profile the expression of these miRNAs in the endometrium throughout the menstrual cycle and at eutopic and ectopic endometrium at various stages of endometriosis. In addition, correlation of expression of specific genes targeted by some of these miRNAs would allow establishing their biological relevance to endometrial Using realtime PCR we validated the expression of hsa-miR20a, hsa-miR21, hsa-miR26a, hsamiR18a, hsa-miR181a, hsa-miR206 and hsa-miR142-5p in these tissues and observed some difference in the level of their expression as compared to microarray analysis. Although microarray profiling did not show a significant difference in the level of expression of some of these miRNAs among the tissues, they were selected because of their predicated target genes which include TGF-β, TGF-β receptors, ERα, ERβ and PR, respectively (Table 3 , Adams et al., 2007) . The difference between microarray and realtime PCR results could be attributed to detection of both precursor and mature forms of miRNAs by microarray and mature form by realtime PCR (Lee et al., 2006) . The results provided additional evidence for differential expression of these miRNAs in the endometrium, more specifically between paired eutopic and ectopic endometrium, although correlating their expression with the expression of target genes is necessary.
However, a large number of target genes for a single miRNA, and multiple miRNAs targeting the expression of one gene have been recognized as a major drawback in assessment of specific target gene regulated by a given miRNA at the transcriptional or translational levels. It has been suggested that prediction of such high number of genes regulated by a single miRNA contain a significant fraction of falsepositive genes and procedures have been recommended to assess the genes with a potential functional relevance in specific tissue biology (Chaudhuri and Chatterjee 2007) . Although the expression of many of the genes regulated by these miRNAs (Table 3) have been identified in the endometrium during the menstrual cycle, in ectopic endometrium and in isolated endometrial cells (Hever et al., 2006; Wu et al., 2006; Ponnampalam et al., 2004; Matsuzaki et al., 2004; Riesewijk et al., 2003; Kao et al., 2002; Eyster et al., 2002) , it is essential to correlate the expression of a number of these genes with their corresponding miRNAs.
Functionally, TGF-β and TGF-β receptor signaling pathways have been associated with several normal cyclic endometrial activities and uterine disorders including endometriosis (Chegini and Williams 2000; Chegini et al., 2003; Luo et al., 2003 Luo et al., ,2004 . In addition, differential expression of ERα, ERβ and PR in ectopic endometrium is considered to reflect their response to ovarian steroid actions (Bulun et al., 2006) . Despite some discrepancies both eutopic and ectopic tissues express ERα and ERβ with predominantly higher levels of ERα and higher relative ratio of ERα:ERβ in ectopic endometrium with the expression detected in both epithelial and stromal cells (Matsuzaki et al., 2000; 2001) . With respect to progesterone receptors, the ectopic endometrium is reported to only express PR-A, while eutopic endometrium express both PR-A and PR-B (Attia et al., 2000) . As such altered expression of hsa-miR20a, hsa-miR21, hsa-miR26, hsa-miR18a, hsa-miR181, hsa-miR206 and hsa-miR142-5p in EC as compared to EN and EU could influence the stability of TGF-β, TGF-β receptors, ERα, ERβ and PR, and other target genes resulting in changes in their local actions and the outcome of endometriosis. Functional analysis also
indicates that the expression of these miRNAs is associated with cellular apoptosis, differentiation, cell-cell communication, and tumorogenesis, with their genes localized to sites of frequent chromosomal instability (Chan et al., 2005; Meng et al., 2006; Si et al., 2006) .
We also provided evidence that ovarian steroids influence the expression of hsa-miR20a, hsamiR21 and hsa-miR26a in ESC and GEC. The molecular mechanism by which ovarian steroids regulate the expression of miRNAs requires detailed investigation however; such a regulatory function may alter the expression of their target genes and the outcome of cellular activities manifested by their products. We also found that ICI-182780 and RU486, alone or in combination with E2 and MPA in part altered the expression of these miRNAs. We believe this is the first such demonstration Figure   2A shows the expression of hsa-miR20a, hsa-miR21, hsa-miR26a and Figure 2B the expression of hsamiR18a, hsa-miR206 hsa-miR181a, and hsa-miR142-5p. Asterisks ** and *** are significantly different from *. A probability level of P<0.05 was considered significant. Arrows point out to difference between eutopic and ectopic tissues.
Are ** and *** different p values?
It would be helpful if EN, EU, EC and EE could be added to the x axis labels to make it easier for the reader to match with the text. cell/6-well plates) were cultured as described in materials and methods and their total RNA was isolated and subjected to real-time PCR. The data is presented as relative expression following normalization and setting their individual expression levels in HES arbitrarily as 1.
Data represent mean ± standard error from 3 separate experiments with asterisks ** and *** significantly different from *, and ** different from *** with a probability level of P<0.05 was considered significant. The list of differentially expressed miRNAs identified in endometrium of women without endometriosis (EN), paired eutopic (EU) and ectopic endometrium (EC), and ectopic endometrium (EE, without paired eutopic tissues). The normalized mean expression values were derived from median spot intensity determined according to the procedure described in the materials and methods section. After global normalization of the raw array data from the 16 samples using the VSN method, the average miRNA expression in EN was compared with their mean expression values in EU, EC and EE using AVOVA with the p values presented in the column on the right. The distribution of expression patterns of these miRNAs is shown in Figure  1 with each miRNA spot sized and color-coded using the standard deviation of expression values (STDEV) within the EN, EU, EC and EE, respectively. The list of differentially expressed miRNAs identified in isolated endometrial glandular epithelial cells (GEC) and stromal cells (ESC) with their normalized mean expression derived from median spot intensity determined according to the procedure described in the materials and methods section. After global normalization of the raw array data using the VSN method, their average miRNA expression in GEC was compared with their expression in ESC using Student t test with the p values shown in the column on the right. 
